10 results
Insulin Analogs - Short, Intermediate and Long Acting - Onset, Peak, Duration

#Diabetes #Insulin #Analogs #Onset #Duration
Insulin Analogs ... , Duration #Diabetes ... Duration #Peaks #Comparison ... #Pharmacology # ... Endocrinology #Timing
The principles of insulin adjustment guidance - Schematic diagram of insulin onset and time action profiles
principles of insulin ... and Duration #Diabetes ... Duration #Peaks #Comparison ... #Pharmacology # ... Endocrinology #Timing
Insulin and analogues onset of action, peak times and duration.

Follow at www.instagram.com/rxnotes for more!

#pharmacology #table #comparison
Insulin and analogues ... #pharmacology #table ... #comparison #dosing ... #insulin #diabetes ... onset #duration #timing
Diabetes Medications Summary Table
Insulin
Lifestyle modifications
Metformin
Sulfonylureas
GLP-1 receptor agonists - ↓ major adverse CV events
TZDs
DPP-4 inhibitors
SGLT2 inhibitors -
Diabetes Medications ... Summary Table Insulin ... modifications Metformin ... medications #table #comparison ... endocrinology #dm2
Effects on body weight of various classes of type-2 diabetes medications.
 - Metformin - Weight Loss
classes of type-2 diabetes ... - Metformin - ... Weight Gain ++ - Insulin ... weightloss #weightgain #comparison ... #pharmacology #
Metformin Pharmacology Summary
Mechanisms of Action:
 • Suppresses gluconeogenesis by the liver
 • Increases insulin-mediated glucose utilization
Metformin Pharmacology ... • Increases insulin-mediated ... EricsMedicalLectures/ #Metformin ... #Pharmacology # ... Summary #DM2 #diabetes
Oral Hypoglycemics in Diabetes Management
1  INSULIN SENSITIZER
 • TZD 
     -
Hypoglycemics in Diabetes ... Management 1 INSULIN ... Sensitivity - Metformin ... #Management #pharmacology ... #DM2 #DMII #Classification
Diabetes Mellitus Type 2 Inpatient Medication Guide

Classes: Biguanide, Sulfonylurea, TZD, DPP-4 inhibitor, GLP-1 receptor agonist, SGLT2i,
Diabetes Mellitus ... in Type 1 Diabetes ... #Mellitus #DM2 ... #Medications #pharmacology ... #comparison #table
Management of Diabetes Mellitus in Patients With CKD

1. Monitor for changes in BP, serum creatinine, &
ml/min per 1.73 m2 ... with metformin. ... evidence-based pharmacologic ... #KDIGO #eGFR #Insulin ... #metformin #ACEi
DPP4 Inhibitors - Normal and Renal Dosing

Increase Incretins (GLP-I & GIP) -> Stimulates Insulin, Inhibits Glucagon
-> Stimulates Insulin ... One unique thing ... Renal #Dosing #Pharmacology ... #Management #Diabetes ... #DM2 #Endocrinology